Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentAcknowledgements
View the documentScientific writers
View the documentIntroduction
View the documentTake-home messages
Open this folder and view contentsSection I - Setting the scene
Open this folder and view contentsSection II - Improving adherence rates: guidance for countries
Close this folderSection III - Disease-Specific Reviews
Open this folder and view contentsChapter VII - Asthma
Open this folder and view contentsChapter VIII - Cancer (Palliative care)
Open this folder and view contentsChapter IX - Depression
Open this folder and view contentsChapter X - Diabetes
Close this folderChapter XI - Epilepsy
View the document1. Introduction
View the document2. Adherence to epilepsy therapy
View the document3. Epidemiology of adherence
View the document4. Factors affecting adherence and interventions used to improve it
View the document5. Conclusions
View the document6. References
Open this folder and view contentsChapter XII - Human immunodeficiency virus and acquired immunodeficiency syndrome
Open this folder and view contentsChapter XIII - Hypertension
Open this folder and view contentsChapter XIV - Tobacco smoking cessation
Open this folder and view contentsChapter XV - Tuberculosis
Open this folder and view contentsAnnexes
Open this folder and view contentsWhere to find a copy of this book
 

3. Epidemiology of adherence

Adherence can vary from an occasional missed dose to chronic defaulting on medication regimens (21). Adherence to antiepileptic drugs in patients with epilepsy generally ranges from 20 to 80% (12,19 - 21). Some studies reported different ranges of adherence for adult patients (40 - 60%) and children (25 - 75%) (3,12).

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014